Home
- Destinations
- Vaccinations
- News & Announcements
- Travel Notices
- Diseases
- Yellow Book
- Find a Clinic
- Specific Groups & Settings
- Seasonal Flu & Travel
- Earthquake, Tsunami, and Radiation Release in Japan: Travel Information
- Traveling with Children
- Special Needs
- Disaster Relief
- Avian Flu & Travel
- Air & Cruise Ship Travel
- Air Travel Information For Travelers
- Cruise Ship Information for Travelers
- For Industry: Air
- CDC Measles Guidance for Commercial Aircraft Operators
- Interim Guidance for Protecting Travelers on Commercial Aircraft Serving Haiti During the Cholera Outbreak
- Reporting Onboard Deaths or Illnesses to CDC
- Onboard Death and Illness Response Tool for Cabin Crew
- Onboard Death and Illness Reporting Tool for Pilots
- CDC Guidance for Commercial Aircraft Operators: Seasonal Influenza
- Infection Control Guidelines for Cabin Crew Members on Commercial Aircraft
- For Industry: Cruise Ships
- Stay Healthy & Safe
- Illness & Injury Abroad
- Resources & Training
- Travel Podcasts
- RSS Feeds
Related Links
Chapter 3Infectious Diseases Related To Travel
Trypanosomiasis, African (Human African Trypanosomiasis, African Sleeping Sickness)
Anne Moore
INFECTIOUS AGENT
Two subspecies of the protozoan parasite Trypanosoma brucei (T. b. rhodesiense and T. b. gambiense) cause infection.
MODE OF TRANSMISSION
Infection occurs through vectorborne transmission by the bite of an infected tsetse fly (Glossina spp.). Transmission via bloodborne or congenital routes can occur but is rarely reported.
EPIDEMIOLOGY
Human African trypanosomiasis (HAT), or African sleeping sickness, is transmitted only in rural sub-Saharan Africa. The 2 human-infective subspecies of T. brucei do not overlap in geographic distribution. T. b. rhodesiense is found in eastern and southeastern Africa. More than 95% of the cases of T. b. rhodesiense infection occur in Tanzania, Uganda, Malawi, and Zambia. T. b. gambiense is found predominately in central Africa and in limited areas of West Africa. More than 95% of the cases of T. b. gambiense infection are reported from the Democratic Republic of the Congo, Angola, Sudan, Central African Republic, Republic of the Congo, Chad, and northern Uganda.
Infection of international travelers occurs but is rare. On average, a single case per year is reported among US travelers. Most infections in US travelers are caused by T. b. rhodesiense and are acquired in East Africa game parks.
Tsetse flies inhabit rural areas, living in the woodlands and thickets of the savannah and the dense vegetation along streams. Less than 1% of flies are infected in a typical endemic area. Tsetse flies bite during daylight hours. Most bites that occur on the African savannah are quite painful, and travelers often recall the bite. Travelers to urban areas are not at risk.
CLINICAL PRESENTATION
Presentation is variable and depends on the infecting subspecies. Infection with T. b. rhodesiense is more acute clinically and progresses more rapidly than T. b. gambiense. Symptoms and signs of T. b. rhodesiense infection generally appear within 1–3 weeks of the infective bite. These may include high fever, a chancre at the site of the infective bite, skin rash, headache, myalgia, thrombocytopenia, and less commonly, splenomegaly, renal failure, or cardiac dysfunction. Central nervous system involvement can occur within the first month of infection.
Symptoms of T. b. gambiense infection are nonspecific, and patients may remain paucisymptomatic for many months after infection. Symptoms and signs may include fever, headache, malaise, myalgia, facial edema, pruritus, lymphadenopathy, and weight loss. Central nervous system involvement occurs after months of infection and is characterized by somnolence, severe headache, and a wide range of neurologic manifestations, including mood disorders, behavior change, focal deficits, and endocrine disorders. Untreated HAT is eventually fatal.
DIAGNOSIS
Diagnosis is made by microscopic identification of parasites in specimens of blood, chancre fluid or tissue, lymph node aspirate, or cerebrospinal fluid. Buffy-coat preparations concentrate the parasite. Parasitemias are higher in T. b. rhodesiense than in T. b. gambiense infection. Serologic tests are not helpful for diagnosis of T. b. rhodesiense. CDC can help arrange serologic testing for T. b. gambiense, which is not available in the United States. Diagnostic assistance is available through CDC’s Division of Parasitic Diseases and Malaria (www.dpd.cdc.gov/dpdx).
TREATMENT
Travelers who sustain tsetse fly bites and become ill with high fever or other manifestations of HAT are advised to seek early medical attention. The infection can usually be cured by a course of antitrypanosomal therapy. Imported HAT is rare in the United States, and inexperienced physicians should consult with an infectious disease or tropical medicine specialist for diagnosis and treatment. Physicians can consult with CDC for assistance with diagnosis and clinical management (404-718-4745, ncidpbdpi@cdc.gov). Treatment drugs (suramin, melarsoprol, eflornithine) are provided by CDC under investigational protocols.
PREVENTIVE MEASURES FOR TRAVELERS
No vaccine or drug for prophylaxis is available. Preventive measures are aimed at reducing contact with tsetse flies. Areas of heavy infestation tend to be sporadically distributed and are usually well known to local residents. Avoidance of these areas is the best means of protection.
Tsetse flies are attracted to moving vehicles and bright, dark colors. The flies can bite through light-weight clothing. Travelers are advised to wear clothing of wrist and ankle length made of medium-weight fabric in neutral colors that blend with the background environment for the best means of protection. Data are limited but suggest that permethrin-impregnated clothing and use of DEET repellent may minimally reduce the number of fly bites. Regardless, use of repellents can reduce bites of mosquitoes and other insects and arthropods, which helps protect against other infectious diseases.
BIBLIOGRAPHY
- Braakman HM, van de Molengraft FJ, Hubert WW, Boerman DH. Lethal African trypanosomiasis in a traveler: MRI and neuropathology. Neurology. 2006 Apr 11;66(7):1094–6.
- Brun R, Blum J, Chappuis F, Burri C. Human African trypanosomiasis. Lancet. 2010 Jan 9;375(9709): 148–59.
- Moore AC, Ryan ET, Waldron MA. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 20-2002. A 37-year-old man with fever, hepatosplenomegaly, and a cutaneous foot lesion after a trip to Africa. N Engl J Med. 2002 Jun 27;346(26):2069–76.
- Moore DA, Edwards M, Escombe R, Agranoff D, Bailey JW, Squire SB, et al. African trypanosomiasis in travelers returning to the United Kingdom. Emerg Infect Dis. 2002 Jan;8(1):74–6.
- Sholdt LL, Schreck CE, Mwangelwa MI, Nondo J, Siachinji VJ. Evaluations of permethrin-impregnated clothing and three topical repellent formulations of deet against tsetse flies in Zambia. Med Vet Entomol. 1989 Apr;3(2):153–8.
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348 - New Hours of Operation
8am-8pm ET/Monday-Friday
Closed Holidays - Contact CDC-INFO